13F-HR filed by SECTORAL ASSET MANAGEMENT INC
SECTORAL ASSET MANAGEMENT INC filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-13, with 64 holding rows worth $2,229,435,000.
- Accession
- 0001104659-15-010210
- Filer
- CIK 1274413
- Filed
- 2015-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2014
A holdings report, 64 entries on the cover page, a total value of $2,229,435,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,229,435,000 with VALUE read as thousands by filing date, 13F file number 028-10653. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BIOGEN INC COM | 09062X103 | Stock | 439,428 | $149,164,000 | thousands by filing date | |
| Amgen Inc. | 031162100 | COM | 894,473 | $142,481,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 1,134,258 | $126,878,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 1,253,243 | $113,293,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 1,332,814 | $97,442,000 | thousands by filing date | |
| MYLAN INC | 628530107 | COM | 1,519,368 | $85,647,000 | thousands by filing date | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,380,888 | $79,415,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 185,685 | $76,177,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 385,624 | $71,352,000 | thousands by filing date | |
| ACTAVIS PLC | G0083B108 | SHS | 256,850 | $66,116,000 | thousands by filing date | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 520,686 | $65,237,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 684,307 | $64,503,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 1,135,130 | $58,766,000 | thousands by filing date | |
| NPS PHARMACEUTICALS INC | 62936P103 | COM | 1,623,073 | $58,057,000 | thousands by filing date | |
| SHIRE PLC | 82481R106 | COMMON STOCK-FO | 236,124 | $50,186,000 | thousands by filing date | |
| KERYX BIOPHARMACEUTICALS | 492515101 | COMMON STOCK | 3,257,358 | $46,092,000 | thousands by filing date | |
| Mallinckrodt Plc | G5785G107 | SHS | 400,664 | $39,678,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 4,765,498 | $39,649,000 | thousands by filing date | |
| PERRIGO CO PLC SHS | G97822103 | Stock | 232,068 | $38,792,000 | thousands by filing date | |
| DR REDDYS LABS LTD ADR | 256135203 | ADR | 762,969 | $38,492,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 1,209,914 | $37,689,000 | thousands by filing date | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 3,724,351 | $35,940,000 | thousands by filing date | |
| MEDIVATION INC | 58501N101 | COM | 356,806 | $35,541,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 1,104,075 | $35,474,000 | thousands by filing date | |
| ONCOMED PHARMACEUTICALS INC COM | 68234X102 | Stock | 1,598,293 | $34,779,000 | thousands by filing date | |
| ALLERGAN INC | 018490102 | COM | 162,750 | $34,599,000 | thousands by filing date | |
| SYNAGEVA BIOPHARMA CORP | 87159A103 | COM | 363,884 | $33,765,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 1,120,379 | $31,729,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 2,373,810 | $29,079,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 181,847 | $28,368,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 713,995 | $27,817,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 212,250 | $25,215,000 | thousands by filing date | |
| RELYPSA INC | 759531106 | Common Stock | 811,330 | $24,989,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 423,452 | $23,713,000 | thousands by filing date | |
| MEDTRONIC INC | 585055106 | COM | 310,025 | $22,384,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 162,880 | $21,091,000 | thousands by filing date | |
| SAGENT PHARMACEUTICALS INC | 786692103 | COM | 833,861 | $20,938,000 | thousands by filing date | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 529,920 | $19,835,000 | thousands by filing date | |
| Abbott Laboratories | 002824100 | COM | 405,410 | $18,252,000 | thousands by filing date | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 34,416 | $18,204,000 | thousands by filing date | |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 1,459,603 | $17,574,000 | thousands by filing date | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 309,031 | $17,278,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 286,065 | $15,748,000 | thousands by filing date | |
| AKORN INC | 009728106 | COM | 434,343 | $15,723,000 | thousands by filing date | |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 807,012 | $14,470,000 | thousands by filing date | |
| HEARTWARE INTL INC | 422368100 | COM | 168,525 | $12,375,000 | thousands by filing date | |
| HCA Healthcare Inc | 40412C101 | COM | 144,002 | $10,568,000 | thousands by filing date | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 185,285 | $7,841,000 | thousands by filing date | |
| AMPHASTAR PHARMACEUTICALS IN | 03209R103 | COM | 660,232 | $7,665,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 708,585 | $6,965,000 | thousands by filing date | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 61,666 | $6,861,000 | thousands by filing date | |
| INOGEN INC | 45780L104 | COM | 206,734 | $6,485,000 | thousands by filing date | |
| NOVARTIS AG SPONSORED ADR | 66987V109 | ADR | 63,500 | $5,884,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 104,300 | $3,034,000 | thousands by filing date | |
| ATRIUM THERAPEUTICS INC | N71546100 | COM | 111,432 | $2,089,000 | thousands by filing date | |
| ZS PHARMA INC | 98979G105 | Common Stock | 47,895 | $1,991,000 | thousands by filing date | |
| ACCURAY INC DEL | 004397105 | COM | 226,300 | $1,709,000 | thousands by filing date | |
| ADVAXIS INC | 007624208 | COM NEW | 210,850 | $1,689,000 | thousands by filing date | |
| Tandem Diabetes Care, Inc. | 875372104 | COM | 131,422 | $1,669,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 94,101 | $1,394,000 | thousands by filing date | |
| WUXI PHARMATECH CAYMAN INC | 929352102 | SPONS ADR SHS | 40,373 | $1,359,000 | thousands by filing date | |
| SESEN BIO, INC. | 286221106 | COM | 112,485 | $1,336,000 | thousands by filing date | |
| IMMUNE DESIGN CORP. | 45252L103 | Common Stock | 21,181 | $652,000 | thousands by filing date | |
| VALEANT PHARMACEUTICALS INTL | 91911K102 | COM | 1,800 | $258,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-15-010210 | this filing | 2015-02-13 | acceptance time not in the bulk data set |